Furin在宫颈癌变过程中的表达及其临床病理意义
被引量:4
摘要
Furin是蛋白前体加工酶家族中的重要成员,与肿瘤的转化、发展与转移密切相关。我们分别检测正常宫颈黏膜、宫颈上皮内瘤变(CIN)及宫颈癌组织中FurinmRNA及蛋白质的表达水平及酶活性,以探讨Furin与宫颈癌变的关系。
出处
《中华病理学杂志》
CAS
CSCD
北大核心
2014年第1期36-37,共2页
Chinese Journal of Pathology
参考文献10
-
1Martin CM,Astbury K,O' Leary JJ. Molecular profiling of cervical neoplasia[J].{H}Expert reviews of Molecular Diagnostics,2006,(2):217-229.
-
2Thomas G. Furin at the cutting edge:from protein traffic to embryogenesis and disease[J].{H}Nature Reviews Molecular Cell Biology,2002,(10):753-766.
-
3Anderson ED,VanSlyke JK,Thulin CD. Activation of the furin endoprotease is a multiple-step process:requirements for acidification and internal propeptide cleavage[J].{H}EMBO Journal,1997,(7):1508-1518.
-
4Bassi DE,Mahloogi H,A1-Saleem L. Elevated furin expression in aggressive human head and neck tumors and tumor cell lines[J].{H}Molecular Carcinogenisis,2001,(4):224-232.
-
5张萍,庞义,杨波,尹崇.弗林蛋白酶—一种重要的前体蛋白内切蛋白酶[J].生物技术通讯,2002,13(2). 被引量:2
-
6Poincloux R,Lizárraga F,Chavrier P. Matrix invasion by tumour cells:a focus on MT1-MMP trafficking to invadopodia[J].{H}Journal of Cell Science,2009,(Pt17):3015-3024.
-
7Bosch FX,de Sanjosé S. Human papillomavirus and cervical cancer:burden and assessment of causality[J].{H}Journal of the National Cancer Institute Monographs,2003,(31):3-13.
-
8Thomison J 3rd,Thomas LK,Shroyer KR. Human papillomavirus:molecular and cytologic/histologic aspects related to cervical intraepithelial neoplasia and carcinoma[J].{H}Human Pathology,2008,(2):154-166.
-
9Reshmi G,Pillai MR. Beyond HPV:oncomirs as new players in cervical cancer[J].{H}FEBS Letters,2008,(30):4113-4116.
-
10Strongin AY. Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy[J].{H}Biochimica et Biophysica Acta,2010,(1):133-141.
二级参考文献21
-
1Roebroek AJ, Schalken JA, Bussemakers MJ et al. Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene[J]. Mol Biol Rep, 1986, 11 (2): 117
-
2Fuller RS, Brake AJ, Thomer J. Intracellular targeting and structural conservation of a prohormone-processing endoprotease [J]. Science, 1989. 246 (4929): 482
-
3Ayoubi TA, Greemers JW, Roebroek Aj et al. Expression of the dibasic proprotein processing enzyme furin is directed by multiple promoters[J]. J Biol Chem, 1994, 269 (12): 9298
-
4Hatsuzawa K, Hosaka M, Nakngawa T et al. Structure and expression of mouse furin, a yeast Kex2-related protease. Lack of processing of coexpressed prorenin in GH4C1 cells [J]. J Biol Chem, 1990, 265 (36): 22075
-
5Zheng M, Streck RD, Scott RE et al. The developmental expression in rat of proteases furin, PCI, PC2, and carboxypeptidase E: implications for early maturation of proteolytic processing capacity[J]. J Neurosci, 1994, 14 (8): 4656
-
6Anderson ED, VanSlyke JK, Thulin CD et al. Activation of the furin endoprotease is a multiple-step process: requirements for acidification and internal propeptide cleavage[J]. EMBO J, 1997,16 (7): 1508
-
7Klimpel KR, Molloy SS, Thomas G et al. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin[J]. Proc Natl Acad Sci USA, 1992, 89 (21): 10277
-
8Tsuneoka M, Nakayama K, Hatsuzawa K et al. Evidence for involvement of furin in cleavage and activation of diphtheria toxin[J]. J Biol Chem, 1993. 268 (35): 26461
-
9Jones BG, Thomas L, Molloy SS et al. Intracellular trafficking of furin is modulated by the phosphorylation state of a casein kinase II site in its cytoplasmic tail[J]. EMBO J. 1995. 14 (23):5869
-
10Siezen RJ, Creemers JW, Van de Ven WJ. Homology modelling of the catalytic domain of human furin. A model for the eukaryotic subtilisin-like proprotein convertases[J]. Eur J Biochem.1994, 222 (2): 255
同被引文献28
-
1才保加,祁玉娟,周为,王晓龙,马玉斌,马晓明.老年胃腺癌患者癌组织Nanog、Oct-4和Furin的表达及意义[J].中国老年学杂志,2014,34(11):2939-2941. 被引量:4
-
2Ming-Hui Zhang,Yi-De Hu,Yu Xu,Yu Xiao,Yan Luo,Zong?Chang Song,Jing Zhou.Human mesenchymal stem cells enhance autophagy of lung carcinoma cellsagainst apoptosis during serum deprivation[J].International Journal of Oncology.2013(4)
-
3Junko Matsuoka,Masakazu Yashiro,Katsunobu Sakurai,Naoshi Kubo,Hiroaki Tanaka,Kazuya Muguruma,Tetsuji Sawada,Masaichi Ohira,Kosei Hirakawa.Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma[J].Journal of Surgical Research.2012(1)
-
4Ting Lin,Yan-Qing Ding,Jian-Ming Li.Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma[J].Medical Oncology.2012(2)
-
5王卫生,唐伟.胚胎干细胞关键因子Nanog在膀胱癌中的表达及与肿瘤干细胞的关系[J].重庆医科大学学报,2009,34(4):409-412. 被引量:7
-
6文雯,冀静,郑鹏生.NANOG基因在宫颈癌中的表达及其意义[J].西安交通大学学报(医学版),2010,31(1):26-31. 被引量:13
-
7王靖雯,杨林青,刘涛,张玉英,高永花,李晓剑,刘飞飞.基质金属蛋白酶-9及血管内皮生长因子在卵巢癌中表达及其关系研究[J].中华实用诊断与治疗杂志,2010,24(7):661-663. 被引量:16
-
8李冬雪,牛朝诗,刘于海,高歌,费小瑞,李明武,董永飞.胶质瘤组织中Nanog基因的表达及其意义[J].中国神经肿瘤杂志,2010,8(1):9-13. 被引量:2
-
9季文,姜政.Nanog基因研究进展[J].医学综述,2011,17(5):672-676. 被引量:4
-
10陆俊杰,陆玉华,朱慧,李晓红,朱铭岩,范向军,朱沙俊,王志伟.Oct4和Nanog在胰腺癌干细胞中表达的研究[J].实用医学杂志,2011,27(16):2900-2904. 被引量:1
引证文献4
-
1才保加,祁玉娟,周为,王晓龙,马玉斌,马晓明.老年胃腺癌患者癌组织Nanog、Oct-4和Furin的表达及意义[J].中国老年学杂志,2014,34(11):2939-2941. 被引量:4
-
2刘恒,石冲,伊凤蕊,戚桂杰.宫颈癌组织中Furin和VEGF的表达研究[J].中国妇幼保健,2018,33(23):5325-5327. 被引量:4
-
3石冲,蔺杰,韩宝生.宫颈癌患者肿瘤组织中弗林蛋白酶的表达与临床病理因素及局部免疫功能的关系[J].中国临床研究,2017,30(10):1315-1318. 被引量:2
-
4石冲,刘恒,张国彬,蔺杰,刘志明.宫颈癌中Furin表达与肿瘤浸润炎性细胞亚群的关系[J].癌症进展,2017,15(12):1430-1432. 被引量:5
二级引证文献15
-
1阎蓓,邸石,周广,刘宾磊.HSVGFP在宫颈癌循环肿瘤细胞中的诊断效果及临床价值[J].武汉大学学报(医学版),2020,41(2):235-239.
-
2刘恒,石冲,伊凤蕊,戚桂杰.宫颈癌组织中Furin和VEGF的表达研究[J].中国妇幼保健,2018,33(23):5325-5327. 被引量:4
-
3杨海涛.肺腺癌CT增强值与弗林蛋白酶、基质金属蛋白酶-14表达的关系[J].检验医学与临床,2017,14(4):545-547. 被引量:4
-
4刘恒,石冲,戚桂杰,韩宝生.弗林蛋白酶在宫颈上皮内瘤变中的表达研究[J].中华妇幼临床医学杂志(电子版),2017,13(6):687-691.
-
5彭敏,张玲,罗琼.宫颈癌组织中FOXP^3+ Treg与PD-L1的表达情况及与临床特征的关系分析[J].癌症进展,2019,17(13):1590-1594. 被引量:11
-
6莫梅山,张雪芸,张彩铃.宫颈癌细胞增殖、凋亡与病理学的相关性[J].实用癌症杂志,2020,35(5):713-716. 被引量:4
-
7刘聃,蔡明慧,魏力.子宫颈癌患者血清miRNA-21水平与临床病理因素及预后的关系[J].肿瘤研究与临床,2020,32(5):313-317. 被引量:5
-
8霍安妮,王春佟,刘月合.阿司匹林联合肿瘤坏死因子相关凋亡诱导因子诱导剂对宫颈癌HeLa细胞功能的影响[J].中国临床药理学杂志,2020,36(11):1531-1534. 被引量:2
-
9谷温雯,吕杰强.TFPI-2在宫颈癌组织中的表达及其与VEGF、MVD的相关性研究[J].药物生物技术,2020,27(3):217-220. 被引量:3
-
10罗君花,张华东,丁琪,齐向华.宫颈癌组织中TAMs分布及MIF的表达与其侵袭浸润的相关性[J].实用癌症杂志,2020,35(12):1940-1942. 被引量:1
-
1石素芳,丁晓敏.LEEP刀环形电切治疗宫颈病变疗效观察[J].中国社区医师(医学专业),2012,14(10):176-176.
-
2慕小燕.bcl-2、PTEN在卵巢子宫内膜异位症癌变过程中的作用观察[J].社区医学杂志,2009,7(15):3-4. 被引量:2
-
3郭科军,薛晖,张颐.HIF-1α和VEGF在宫颈癌癌变过程中的表达及意义[J].中国医科大学学报,2008,37(2):237-239. 被引量:7
-
4杨峥莉,刘荣霞,郝国荣.宫颈癌癌变过程中Fas、Survivin的表达及其临床意义[J].临床合理用药杂志,2008,1(1):10-11.
-
5钱建华,石一复.bcl-2、p53蛋白表达在卵巢子宫内膜异位症癌变过程中的作用[J].中华肿瘤杂志,2001,23(5):403-405. 被引量:10
-
6钱建华,石一复.子宫内膜异位症癌变过程中内膜组织DNA微卫星不稳定性的检测[J].中华妇产科杂志,2001,36(12):755-756. 被引量:1
-
7叶霞,陈玲.PTEN蛋白表达在卵巢子宫内膜异位症癌变过程中的变化及意义[J].山西医药杂志(下半月),2013,42(11):1235-1236. 被引量:1
-
8张丽洁,王莉芬,王艳华.β-catenin和DKK-1在子宫内膜样腺癌中的表达及意义[J].大连医科大学学报,2010,32(6):639-642. 被引量:2
-
9张颖,王庆一,梁艳红,陈海玲.P53、P16、PTEN、hMLH1蛋白表达与卵巢子宫内膜异位症癌变的关系[J].新医学,2010,41(6):379-382. 被引量:7
-
10史红,刘雪梅,赵文霞,方士华,徐珊,朱向宇,崔芳,张国庆.水通道蛋白1在宫颈鳞状上皮癌变过程中的表达及意义[J].中国妇幼保健,2015,30(12):1911-1913. 被引量:1